🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 501147102
- Market Cap
- Micro Cap · $96 Million
- IPO
- 9/20/2017 · $10.00/share
Business: Krystal Biotech, Inc. is a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases. The Company has a proprietary gene therapy platform, which the Company refers to as the Skin TARgeted Delivery platform, or STAR-D platform, which the Company is initially using to develop treatments for rare or orphan dermatological indications.
Company Contact
- CEO
- Krish S. Krishnan
- CFO
- Antony Riley
- Headquarters
- 2100 Wharton Street, Suite 701, Pittsburgh, PA 15203
- Phone
- 412-586-5830
- Investor Relations
- Ashley R. Robinson, LifeSci Advisors · 412-586-5830 · arr@lifesciadvisors.com